Healthcare market research in the United States
Managing US Healthcare: What Drives Patient & Payer Decisions?
The United States healthcare market, valued at over scoped per brief trillion, presents unique research challenges due to its complex regulatory environment and diverse patient populations.
Compliance with HIPAA (Health Insurance Portability and Accountability Act) is fundamental for any data collection involving protected health information. Additionally, state-specific privacy laws, such as the CCPA/CPRA in California, add layers of consideration for respondent data.
Global Vox Populi is equipped to handle these intricate requirements, providing reliable healthcare market research in the United States.
What we research in the United States
We help clients understand critical aspects of the US healthcare environment. Our projects often explore treatment journey mapping, identifying key decision points for patients and healthcare professionals (HCPs).
We conduct market access studies to assess payer perceptions and reimbursement hurdles for new therapies. Patient experience and satisfaction research is central to improving care delivery. We also focus on HCP segmentation, understanding their referral patterns, and evaluating medical device concept testing.
Pharmaceutical brand health tracking and message testing are common, delivering effective communication in a competitive market. Every project scope is customized to address the specific business questions of the brief.
Why Healthcare market research fits (or struggles) in the United States
Healthcare market research in the United States benefits from a highly engaged and diverse patient population, particularly for common conditions.
Digital adoption among both patients and HCPs supports online survey and qualitative recruitment, offering broad geographic reach. However, the method faces challenges. Recruiting low-incidence patient populations or niche medical specialists can be complex due to privacy concerns and time constraints.
Physician burnout often impacts participation rates, requiring careful incentive design and efficient interview protocols. The vast geographic spread also makes in-person qualitative work logistically intensive outside major metropolitan areas.
For reaching highly specialized HCPs or rare disease patients, traditional panels may fall short.
In such cases, we often combine our proprietary panels with targeted outreach through professional associations or patient advocacy groups, or recommend in-depth interviews in the United States for nuanced insights from hard-to-reach segments.
How we run Healthcare market research in the United States
Our approach to healthcare market research in the United States begins with sourcing from specialized in-country HCP panels, patient advocacy networks, and validated B2B databases that maintain physician and patient registries.
For general consumer health topics, we may use river sampling or partner with online panel providers. Rigorous screening includes medical specialty verification, NPI (National Provider Identifier) checks for HCPs, and recent participation flags to prevent over-surveying.
We also implement attention checks and open-ended validation questions. Fieldwork primarily uses online surveys (CAWI), webcam-based in-depth interviews (IDIs), and online focus group discussions. For specific needs, we arrange in-person interviews or ethnographies in key metro areas.
We cover English as the primary language, with capabilities for Spanish-speaking populations, especially in states like California, Texas, and Florida. Our moderators and interviewers possess medical or life sciences backgrounds, are trained in ethical healthcare research, and speak native English or Spanish.
Quality assurance involves live monitoring of qualitative sessions, back-checks on respondent eligibility, and thorough review of transcripts and data for consistency. Deliverables range from comprehensive reports and debrief decks to anonymized transcripts, raw data files, and interactive dashboards.
A dedicated project manager maintains transparent communication throughout the project lifecycle.
Where we field in the United States
Our healthcare market research capabilities extend across the entire United States, delivering comprehensive geographic coverage.
We conduct studies in major metropolitan areas such as New York City, Los Angeles, Chicago, Houston, and Miami, where a high concentration of healthcare facilities and diverse patient demographics exist.
Beyond these hubs, our reach includes suburban and rural areas across all 50 states, primarily through online quantitative and qualitative methodologies. This allows us to capture regional variations in healthcare access, patient attitudes, and physician practices.
We frequently conduct research in the Northeast, Mid-Atlantic, Southeast, Midwest, Southwest, Mountain West, and Pacific regions.
While English is the predominant language for our research, we also field projects in Spanish, particularly when targeting Hispanic populations in states like California, Texas, Florida, and Arizona, delivering cultural and linguistic relevance for these key segments.
Methodology, standards, and ethics
We adhere strictly to international and national research standards for all our healthcare market research in the United States.
Our operations are ESOMAR-aligned and fully compliant with the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision). We also align with the Insights Association, the primary professional body for research in the US.
Our methodologies are grounded in established frameworks: semi-structured interview guides for IDIs, patient journey mapping techniques, and validated scales like Net Promoter Score for patient experience.
Applying these standards to healthcare research means meticulous attention to informed consent. All respondents, especially patients and HCPs, receive clear, unambiguous information regarding the research purpose, data usage, and their rights to withdraw.
We implement reliable data anonymization and pseudonymization protocols to protect Protected Health Information (PHI) in accordance with HIPAA. Our processes guarantee full transparency about who is sponsoring the research and how their data will be handled.
Quality assurance is integrated at every stage. This includes peer review of all research instruments, such as screeners and discussion guides, by senior researchers. We conduct back-checks to verify respondent eligibility and participation.
Quota validation makes sure representative samples are met, and for quantitative studies, statistical validation checks data integrity. Qualitative transcripts undergo coding verification, and all PII is meticulously redacted before delivery to clients.
Drivers and barriers for Healthcare market research in the United States
DRIVERS:
- The United States healthcare sector is characterized by substantial research and development investment, continuously generating demand for market insights.
- Its large, diverse patient population and sophisticated digital health infrastructure support broad-scale data collection.
- Growing emphasis on patient-centric care and outcomes drives demand for patient experience and journey mapping studies.
- The established regulatory framework, including HIPAA, while complex, provides a clear structure for ethical data handling, which builds trust and participation.
BARRIERS:
- Managing the intricacies of HIPAA compliance and other state-specific privacy laws remains a significant barrier, requiring specialized expertise.
- Physician time constraints and burnout often lead to lower response rates from HCPs, necessitating higher incentives or more creative engagement strategies.
- Recruiting for rare disease indications or highly specialized medical fields presents unique challenges due to low incidence and limited access.
- The fragmented payer environment, with numerous private and public insurers, complicates market access research.
Compliance and data handling under the United States’ framework
For all healthcare market research conducted in the United States, we operate under the stringent requirements of the Health Insurance Portability and Accountability Act (HIPAA), particularly regarding Protected Health Information (PHI).
We also adhere to state-specific data privacy laws, including the California Consumer Privacy Act (CCPA) and its amendment, the California Privacy Rights Act (CPRA), the Virginia Consumer Data Protection Act (VCDPA), the Colorado Privacy Act (CPA), the Connecticut Data Privacy Act (CTDPA), and the Utah Consumer Privacy Act (UCPA).
Our consent capture processes are designed to be explicit and transparent, detailing data collection, usage, and storage. Data residency is managed carefully, with PHI stored on secure, encrypted servers compliant with US regulations. We implement strict data minimization, pseudonymization, and anonymization techniques.
Respondents are fully informed of their rights, including access to their data, correction, and withdrawal of consent, aligning with all applicable US legal frameworks.
Top 20 industries we serve in the United States
Research projects we field in the United States often cover a wide array of sectors, reflecting the country’s diverse economy.
- Pharma & Biotech: HCP segmentation, treatment journey mapping, market access studies, drug concept testing.
- Medical Devices: Device usability testing, physician adoption barriers, surgical procedure mapping.
- Health Insurance: Member satisfaction, claims experience research, plan choice drivers, digital portal usage.
- Hospitals & Health Systems: Patient experience, hospital choice factors, service line expansion research.
- Digital Health & Telemedicine: App usability, virtual care adoption, patient portal engagement.
- Consumer Health & OTC: Brand health tracking, claims testing, product concept testing, shopper insights.
- Banking & Financial Services: Customer experience tracking, digital banking adoption, product concept testing.
- Insurance: Policyholder satisfaction, claims process research, distribution channel effectiveness.
- FMCG & CPG: Pack testing, U&A studies, shopper journey research, new product development.
- Automotive & Mobility: Brand perception, EV adoption intent, post-purchase satisfaction, autonomous vehicle attitudes.
- Retail & E-commerce: Store experience, online conversion funnels, basket analysis, omnichannel strategy.
- Technology & SaaS: Product-market fit research, user experience studies, feature prioritization.
- Telecom: Subscriber satisfaction, churn drivers, 5G adoption, bundled service appeal.
- Media & Entertainment: Content testing, audience segmentation, streaming service preferences.
- Travel & Hospitality: Booking journey research, loyalty program studies, destination perception.
- Energy & Utilities: Customer satisfaction, sustainability perception, smart home energy solutions.
- Real Estate: Buyer journey research, location preference studies, rental market trends.
- Education: Course satisfaction, online learning preferences, parent decision-making for higher education.
- Government & Public Sector: Citizen satisfaction with services, policy research, public opinion polling.
- Logistics & Supply Chain: B2B shipper research, last-mile satisfaction, freight optimization studies.
Companies and brands in our research universe in the United States
Research projects we field in the United States regularly cover the competitive sets of category leaders such as Pfizer, Johnson & Johnson, Merck, UnitedHealth Group, CVS Health, and Apple.
The brands and organizations whose categories shape our research scope in the United States also include Microsoft, Amazon, Walmart, JPMorgan Chase, Bank of America, Procter & Gamble, Coca-Cola, PepsiCo, Ford, General Motors, Tesla, Nike, Starbucks, McDonald’s, Disney, and Netflix.
Why teams choose Global Vox Populi for Healthcare market research in the United States
Teams choose Global Vox Populi for healthcare market research for several key reasons.
- Our US desk operates with senior research directors who possess an average of 15+ years of tenure, bringing deep category expertise.
- We have established access to verified HCP and patient panels, delivering reliable recruitment for even niche segments.
- All qualitative outputs, including transcripts and initial coding, can be delivered while fieldwork is ongoing, supporting faster decision-making.
- Our project management model provides a single project lead from kickoff through debrief, eliminating handoffs and delivering consistent communication.
- We also have a strong track record in integrating complex ethical guidelines, like HIPAA, into our research design and execution.
- If you would like to tell us about your project, we are ready to listen.
- We also have strong capabilities in healthcare market research in Canada.
Frequently Asked Questions
Q: What kinds of clients commission Healthcare market research in the United States?
A: We work with pharmaceutical companies, medical device manufacturers, health insurance providers, hospital systems, and digital health startups. They seek insights for new product development, market access strategies, patient experience improvement, and competitive intelligence. We support both established industry players and innovative entrants managing the US healthcare environment.
Q: How do you deliver sample quality for the United States’ diverse population?
A: We use a multi-pronged approach, drawing from verified HCP panels, patient advocacy groups, and carefully screened general population panels. Our screening protocols include demographic quotas, medical specialty verification, and advanced fraud detection. This delivers representative and qualified samples across the United States’ varied ethnic, socioeconomic, and geographic segments.
Q: Which languages do you cover in the United States?
A: Our primary language for healthcare market research is English. However, we regularly conduct studies in Spanish, particularly for reaching Hispanic populations in key states. We employ native-speaking interviewers and moderators for all non-English projects, making sure cultural nuances are understood and accurately conveyed.
Q: How do you reach hard-to-find audiences (senior B2B, low-incidence consumer segments) in the United States?
A: For hard-to-find audiences like rare disease patients or specific medical specialists, we combine proprietary B2B panels with targeted outreach through professional associations and patient advocacy networks. We also employ referral recruitment and snowball sampling under strict ethical guidelines. This focused approach yields qualified, engaged participants.
Q: What is your approach to data privacy compliance under the United States’ framework?
A: We rigorously comply with HIPAA for Protected Health Information and state laws like CCPA/CPRA for consumer data. Our approach includes explicit informed consent, data minimization, pseudonymization, and secure, encrypted data storage within US jurisdiction. We train our teams continually on the latest privacy regulations, safeguarding all respondent data.
Q: Can you combine Healthcare market research with other methods (FGDs + IDIs, CATI + CAWI, etc.)?
A: Yes, we frequently design hybrid methodologies for US healthcare projects. For instance, combining quantitative surveys (CAWI) to identify prevalence with qualitative in-depth interviews (IDIs) to understand motivations. This mixed-method approach provides both breadth and depth, offering a more complete picture of patient behaviors or HCP perspectives.
Q: How do you manage cultural sensitivity in the United States?
A: Cultural sensitivity is essential in the diverse US market. Our research design considers regional, ethnic, and socioeconomic differences. We use culturally competent moderators and interviewers, particularly for specific ethnic groups. Discussion guides are adapted to local contexts, and we avoid leading questions that might elicit biased responses based on cultural norms.
Q: Do you handle both consumer and B2B research in the United States?
A: Yes, we have extensive experience in both consumer and B2B healthcare market research across the United States. This includes patient research, caregiver studies, and general population health surveys, as well as in-depth engagements with healthcare professionals (HCPs), payers, hospital administrators, and medical device engineers. Our teams are adept at both domains.
Q: What deliverables do clients receive at the end of a Healthcare market research project in the United States?
A: Deliverables are customized to the project scope. Typically, clients receive a comprehensive report with key findings, strategic recommendations, and actionable insights. This often includes a debrief presentation, raw data files, anonymized transcripts for qualitative work, and interactive dashboards for quantitative studies. All outputs are designed for clarity and impact.
Q: How do you handle quality assurance and back-checks?
A: Quality assurance is embedded throughout our process. For quantitative studies, this includes data cleaning, logic checks, and statistical validation. For qualitative, we conduct back-checks to verify participant eligibility and engagement. All fieldwork is monitored, and transcripts are reviewed for accuracy and PII redaction. Senior researchers review all analysis and reports.
When your next research brief involves the United States, let’s talk through it. Request A Quote or View Case Studies from our work.